Annex F - IDA code of conduct |
Fri, 02/24/2023 - 05:52 |
Annex F. CDP technical tender submission - instructions for use ITB-Iplus/GDF-MED/2023/3 |
Thu, 07/20/2023 - 08:56 |
Annex G - GDF access to supplier information for WHO PQP and ERP assessed TB medicines |
Mon, 04/11/2022 - 08:54 |
Annex G - GDF access to supplier information for WHO PQP and ERP assessed TB medicines |
Fri, 02/24/2023 - 05:52 |
Annex G - GDF access to supplier information for WHO PQP and ERP assessed TB medicines ITB-Iplus/GDF-MED/2023/2 |
Fri, 06/23/2023 - 04:10 |
Annex G. GDF access to supplier information for WHO PQP and ERP assessed TB medicines ITB-Iplus/GDF-MED/2023/3 |
Thu, 07/20/2023 - 08:56 |
Annex G. GDF access to supplier information for WHO PQP and ERP assessed TB medicines ITB-Iplus/GDF-MED/2023/4 |
Mon, 08/28/2023 - 06:23 |
Annex G. GDF access to supplier information for WHO PQP and ERP assessed TB medicines ITB-Iplus/GDF-MED/2023/5 |
Fri, 09/08/2023 - 04:12 |
Annex H - Indicative non-binding estimated quantities of products requested |
Mon, 04/11/2022 - 08:54 |
Annex H - Indicative non-binding estimated quantities of products requested |
Fri, 02/24/2023 - 05:53 |
Annex H - Indicative non-binding estimated quantities of products requested ITB-Iplus/GDF-MED/2023/2 |
Fri, 06/23/2023 - 04:11 |
Annex H. Indicative non-binding estimated quantities ITB-Iplus/GDF-MED/2023/3 |
Thu, 07/20/2023 - 08:57 |
Annex H. Indicative non-binding estimated quantities ITB-Iplus/GDF-MED/2023/4 |
Mon, 08/28/2023 - 06:23 |
Annex H. Indicative non-binding estimated quantities ITB-Iplus/GDF-MED/2023/5 |
Fri, 09/08/2023 - 04:14 |
Annex I - GMSD address list |
Mon, 04/11/2022 - 08:55 |
Annex I - GMSDs address list |
Fri, 02/24/2023 - 05:54 |
Annex I - GMSDs address list ITB-Iplus/GDF-MED/2023/2 |
Fri, 06/23/2023 - 04:12 |
Annex I. GMSD address list ITB-Iplus/GDF-MED/2023/3 |
Thu, 07/20/2023 - 08:58 |
Annex J - Global Drug Facility artwork development guidelines |
Mon, 04/11/2022 - 08:55 |
Annex J - Global Drug Facility artwork development guidelines |
Fri, 02/24/2023 - 05:55 |
Annex J - Global Drug Facility artwork development guidelines ITB-Iplus/GDF-MED/2023/2 |
Fri, 06/23/2023 - 04:13 |
Annex J. GDF packaging artwork development guidelines ITB-Iplus/GDF-MED/2023/3 |
Thu, 07/20/2023 - 08:59 |
Annex K - Form for Requests for Clarifications or Complaints |
Mon, 04/11/2022 - 08:56 |
Annex K - Form for Requests for Clarifications or Complaints |
Fri, 02/24/2023 - 05:56 |
Annex K - Form for Requests for Clarifications or Complaints ITB-Iplus/GDF-MED/2023/2 |
Fri, 06/23/2023 - 04:19 |
Annex K. Form for Requests for Clarifications or Complaints after ITB awarding ITB-Iplus/GDF-MED/2023/3 |
Thu, 07/20/2023 - 09:01 |
Annex K. Form for Requests for Clarifications or Complaints after ITB awarding ITB-Iplus/GDF-MED/2023/4 |
Mon, 08/28/2023 - 06:25 |
Annex K. Form for Requests for Clarifications or Complaints after ITB awarding ITB-Iplus/GDF-MED/2023/5 |
Fri, 09/08/2023 - 04:17 |
Annex L - CDP Technical Tender Submission - Instructions for use |
Mon, 04/11/2022 - 08:56 |
Annex L - CDP Technical Tender Submission - Instructions for use |
Fri, 02/24/2023 - 06:07 |
Annex L. Declaration of supply restrictions for bedaquiline 100mg tablets |
Thu, 07/20/2023 - 09:03 |
Annex: Independent External Evaluation of the Global Stop TB Partnership |
Fri, 07/27/2018 - 10:05 |
Announcing Price Reduction for BDQ for Treatment of DR-TB in Low- And Middle-Income Countries |
Mon, 09/13/2021 - 11:45 |
Announcing the call for 2014 Kochon Prize nominations |
Tue, 11/13/2018 - 08:37 |
Announcing the Challenge Facility for Civil Society Round 10 Grantees |
Mon, 10/04/2021 - 07:48 |
Annual Board Meeting |
Mon, 03/20/2023 - 13:42 |